CAST
Calpastatin
Also known as: ICAL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P20810
- Gene
- CAST
- Ensembl
- ENSG00000153113
- Chromosome
- 5
- Canonical length
- 708 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Endoplasmic reticulum,Plasma membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is an endogenous calpain (calcium-dependent cysteine protease) inhibitor. It consists of an N-terminal domain L and four repetitive calpain-inhibition domains (domains 1-4), and it is involved in the proteolysis of amyloid precursor protein. The calpain/calpastatin system is involved in numerous membrane fusion events, such as neural vesicle exocytosis and platelet and red-cell aggregation. The encoded protein is also thought to affect the expression levels of genes encoding structural or regulatory proteins. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jun 2010]
Canonical amino-acid sequenceUniProt
708 residues, UniProt reviewed canonical sequence.
>P20810|CAST
1 MNPTETKAIP VSQQMEGPHL PNKKKHKKQA VKTEPEKKSQ STKLSVVHEK KSQEGKPKEH
61 TEPKSLPKQA SDTGSNDAHN KKAVSRSAEQ QPSEKSTEPK TKPQDMISAG GESVAGITAI
121 SGKPGDKKKE KKSLTPAVPV ESKPDKPSGK SGMDAALDDL IDTLGGPEET EEENTTYTGP
181 EVSDPMSSTY IEELGKREVT IPPKYRELLA KKEGITGPPA DSSKPIGPDD AIDALSSDFT
241 CGSPTAAGKK TEKEESTEVL KAQSAGTVRS AAPPQEKKRK VEKDTMSDQA LEALSASLGT
301 RQAEPELDLR SIKEVDEAKA KEEKLEKCGE DDETIPSEYR LKPATDKDGK PLLPEPEEKP
361 KPRSESELID ELSEDFDRSE CKEKPSKPTE KTEESKAAAP APVSEAVCRT SMCSIQSAPP
421 EPATLKGTVP DDAVEALADS LGKKEADPED GKPVMDKVKE KAKEEDREKL GEKEETIPPD
481 YRLEEVKDKD GKPLLPKESK EQLPPMSEDF LLDALSEDFS GPQNASSLKF EDAKLAAAIS
541 EVVSQTPAST TQAGAPPRDT SQSDKDLDDA LDKLSDSLGQ RQPDPDENKP MEDKVKEKAK
601 AEHRDKLGER DDTIPPEYRH LLDDNGQDKP VKPPTKKSED SKKPADDQDP IDALSGDLDS
661 CPSTTETSQN TAKDKCKKAA SSSKAPKNGG KAKDSAKTTE ETSKPKDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CAST can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 322 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 322 nTPM
- heart muscle: 284 nTPM
- skeletal muscle: 278 nTPM
- vagina: 175 nTPM
- tongue: 155 nTPM
- colon: 150 nTPM
Single-cell type
- esophageal apical cells: 3,886 nCPM
- ocular epithelial cells: 2,239 nCPM
- early spermatids: 1,313 nCPM
- esophageal suprabasal cells: 1,308 nCPM
- urothelial cells: 1,035 nCPM
- suprabasal keratinocytes: 855 nCPM
Immune cell
- classical monocyte: 157 nTPM
- non-classical monocyte: 111 nTPM
- total PBMC: 108 nTPM
- myeloid DC: 108 nTPM
- intermediate monocyte: 86 nTPM
- memory B-cell: 80 nTPM
Brain region
- choroid plexus: 106 nTPM
- medulla oblongata: 89 nTPM
- pons: 83 nTPM
- midbrain: 81 nTPM
- hypothalamus: 79 nTPM
- white matter: 76 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CAST.
Disease | AllUniProt
Conditions CAST is implicated in, by any mechanism.
- Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads (PLACK) MIM:616295
Disease | GeneticClinVar
14 pathogenic / likely-pathogenic of 319 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome
- CAST-related disorder
Disease | ImmuneIEDB
Conditions an epitope on CAST was assayed in.
- rheumatoid arthritis B cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against CAST are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for CAST from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
22 publications
- Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study.
2001 · Arthritis Rheum · RCR 5.9 · 204 citations - Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study.
2004 · Ann Rheum Dis · RCR 2.6 · 99 citations - Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases.
1995 · Proc Natl Acad Sci U S A · RCR 1.6 · 61 citations - Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera.
1995 · J Clin Invest · RCR 1.4 · 54 citations - Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab.
2007 · Rheumatology (Oxford) · RCR 1.3 · 46 citations
Show 17 more
- Autoantibodies directed against the protease inhibitor calpastatin in psoriasis.
2005 · Clin Exp Immunol · RCR 0.6 · 22 citations - Autoantibodies against human calpastatin in rheumatoid arthritis: epitope mapping and analysis of patient sera.
1998 · Br J Rheumatol · RCR 0.6 · 24 citations - Autoantibodies to the 27 C-terminal amino acids of calpastatin are detected in a restricted set of connective tissue diseases and may be useful for diagnosis of rheumatoid arthritis in community cases of very early arthritis.
2001 · Rheumatology (Oxford) · RCR 0.6 · 18 citations - Overexpression of a minimal domain of calpastatin suppresses IL-6 production and Th17 development via reduced NF-κB and increased STAT5 signals.
2011 · PLoS One · RCR 0.5 · 20 citations - High diagnostic value of anticalpastatin autoantibodies in rheumatoid arthritis detected by ELISA using human erythrocyte calpastatin as antigen.
2004 · J Rheumatol · RCR 0.4 · 20 citations - Calpastatin autoantibodies: detection, epitope mapping, and development of a specific peptide ELISA.
1996 · Clin Chem · RCR 0.4 · 10 citations - HLA-DRB1*0404 is strongly associated with anticalpastatin antibodies in rheumatoid arthritis.
2007 · Ann Rheum Dis · RCR 0.3 · 14 citations - Autoantibodies against calpastatin in sera from patients with systemic sclerosis.
1998 · J Rheumatol · RCR 0.2 · 6 citations - Autoantibodies directed against the amino-terminal domain I of human calpastatin (ACAST-DI Ab) in connective tissue diseases. High levels of ACAST-DI Ab are associated with vasculitis in lupus.
2002 · J Autoimmun · RCR 0.2 · 6 citations - Autoantibodies against the protease inhibitor calpastatin: a new risk factor for venous thrombosis?
1997 · Thromb Haemost · RCR 0.2 · 6 citations - Autoantibodies recognizing the 27 carboxy-terminal amino acids of calpastatin are associated with secondary Sjögren syndrome in systemic lupus erythematosus.
2004 · Lupus · RCR 0.1 · 2 citations - [Detection of isotype-specific autoantibodies to calpastatin in sera from patients with rheumatic diseases using heat-treated HeLa cell extract as an antigen source for immunoblotting].
1998 · Nihon Rinsho Meneki Gakkai Kaishi · RCR 0.1 · 2 citations - [Antigenic epitopes recognized by autoantibodies to calpastatin in patients with rheumatoid arthritis and their clinical significance].
1997 · Ryumachi · RCR 0 · 1 citations - Domain reactivity of autoantibodies to calpastatin in patients with systemic rheumatic diseases.
2000 · Mod Rheumatol · RCR 0 · 2 citations - [Anti-calpastatin antibody as a serological marker for the diagnosis of rheumatoid arthritis].
2005 · Nihon Rinsho - [Examination of rheumatoid factor and other serum markers in rheumatoid arthritis].
2005 · Yakugaku Zasshi - [The pathogenic role and production system of autoantibody in rheumatoid arthritis].
2005 · Nihon Rinsho Meneki Gakkai Kaishi
Reference: B cellIEDB
1 publication
- HLA-DRB1*0404 is strongly associated with anticalpastatin antibodies in rheumatoid arthritis.
2007 · Ann Rheum Dis · RCR 0.3 · 14 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.78
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.38
- DepMap mean gene effect
- -0.28
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of type B pancreatic cell apoptotic process
- presynaptic active zone organization
Molecular functions
- cadherin binding
- endopeptidase inhibitor activity
- RNA binding
- calcium-dependent cysteine-type endopeptidase inhibitor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Proteinase inhibitor I27, calpastatin
- Calpastatin
- Calpain inhibitor
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CAST as an antibody target. Whether an autoantibody or antibody against CAST could matter depends on whether native CAST is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CAST is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CAST as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...